CLINICAL_TRIALS
trial_result
· 2015-01-13
Clinical Trial Update: Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients. [Phase 3]
Summary
Phase 3 trial evaluated the efficacy and safety of BIA 9-1067 in idiopathic Parkinson's disease; results were posted in January 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-01-13